Trial Profile
Clinical Trials Insight: 700055435
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 Apr 2010
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Romark Laboratories
- 16 Apr 2010 New trial record